Liều thấp đến tim trong thực hành hàng ngày để điều trị ung thư vú bên trái bằng xạ trị liều một phần vú tăng tốc thông qua điều trị bức xạ đa catheter và giữ hơi thở sâu sử dụng SIB
Tóm tắt
Từ khóa
Tài liệu tham khảo
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 19(1):27–39
Wang HY, Yin BB, Jia DY, Hou YL (2017) Association between obesity and trastuzumab-related cardiac toxicity in elderly patients with breast cancer. Oncotarget 8(45):79289–79297
Denegri A, Moccetti T, Moccetti M, Spallarossa P, Brunelli C, Ameri P (2016) Cardiac toxicity of trastuzumab in elderly patients with breast cancer. J Geriatr Cardiol 13(4):355–363
Guo S, Wong S (2014) Cardiovascular toxicities from systemic breast cancer therapy. Front Oncol 4:346
Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D et al (2013) Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 368(11):987–998
Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R et al (2019) Heart toxicity from breast cancer radiotherapy : current findings, assessment, and prevention. Strahlenther Onkol 195(1):1–12
Cai G, Li C, Li J, Yang J, Li C, Sun L et al (2023) Cardiac substructures dosimetric predictors for cardiac toxicity after definitive radiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys 115(2):366–381. https://doi.org/10.1016/j.ijrobp.2022.08.013
Merzenich H, Bartkowiak D, Schmidberger H, Schmidt M, Schwentner L, Wiegel T et al (2017) 3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study). Breast Cancer Res Treat 161(1):143–152
Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R et al (2019) Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO). Strahlenther Onkol 195(10):861–871
Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T et al (2016) 5‑year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387(10015):229–238
Shah C, Vicini F, Shaitelman SF, Hepel J, Keisch M, Arthur D et al (2018) The American brachytherapy society consensus statement for accelerated partial-breast irradiation. Brachytherapy 17(1):154–170
AWMF (2021) Interdisziplinäre S3-Leitlinie für die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms
Alonso C, Janowski E, Libby B, Showalter S (2018) Comparison of heart dose in early-stage left-sided breast cancers treated with intraoperative radiation therapy or whole-breast irradiation with deep inspiratory breath hold. Brachytherapy 17(5):831–836
Dutta SW, Aliotta E, Alonso CE, Bliley RC, Romano KD, Libby B et al (2020) Normal tissue dose and risk estimates from whole and partial breast radiation techniques. Breast J 26(7):1308–1315. https://doi.org/10.1111/tbj.13735
Lettmaier S, Kreppner S, Lotter M, Walser M, Ott OJ, Fietkau R, Strnad V (2011) Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiother Oncol 100(2):189–194
Herein A, Stelczer G, Pesznyak C, Frohlich G, Smanyko V, Meszaros N et al (2021) Multicatheter interstitial brachytherapy versus stereotactic radiotherapy with CyberKnife for accelerated partial breast irradiation: a comparative treatment planning study with respect to dosimetry of organs at risk. Radiol Oncol 55(2):229–239
Major T, Frohlich G, Agoston P, Polgar C, Takacsi-Nagy Z (2022) The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlenther Onkol 198(2):93–109
Major T, Stelczer G, Pesznyak C, Meszaros N, Polgar C (2017) Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: a comparative treatment planning study with respect to dosimetry of organs at risk. Radiother Oncol 122(1):17–23
Strnad V, Hannoun-Levi JM, Guinot JL, Lossl K, Kauer-Dorner D, Resch A et al (2015) Recommendations from GEC ESTRO breast cancer working group (I): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving closed cavity surgery. Radiother Oncol 115(3):342–348
Kirby AM (2018) Updated ASTRO guidelines on accelerated partial breast irradiation (APBI): to whom can we offer APBI outside a clinical trial? Br J Radiol 91(1085):20170565
Major T, Gutierrez C, Guix B, van Limbergen E, Strnad V, Polgar C, Breast Cancer Working Group of GEC-ESTRO (2016) Recommendations from GEC ESTRO breast cancer working group (II): target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving open cavity surgery. Radiother Oncol 118(1):199–204
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Sola AB et al (2016) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1. Radiother Oncol 118(1):205–208
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A et al (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114(1):3–10
Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L et al (2011) Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys 79(1):10–18
Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P et al (2021) Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: considerations regarding FAST and FAST-forward. Strahlenther Onkol 197(4):269–280
Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A et al (2020) Ten-year results of FAST: a randomized controlled trial of 5‑fraction whole-breast radiotherapy for early breast cancer. J Clin Oncol 38(28):3261–3272
Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Feyer P, Fietkau R et al (2013) Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Strahlenther Onkol 189(3):193–196
Schultz-Hector S, Sund M, Thames HD (1992) Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother Oncol 23(1):33–40
Lauk S, Ruth S, Trott KR (1987) The effects of dose-fractionation on radiation-induced heart disease in rats. Radiother Oncol 8(4):363–367
Holliday EB, Kirsner SM, Thames HD, Mason BE, Nelson CL, Bloom ES (2017) Lower mean heart dose with deep inspiration breath hold-whole breast irradiation compared with brachytherapy-based accelerated partial breast irradiation for women with left-sided tumors. Pract Radiat Oncol 7(2):80–85